Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Association of interleukin-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus.

Ho KT, Shiau MY, Chang YH, Chen CM, Yang SC, Huang CN.

Metabolism. 2010 Dec;59(12):1717-22. doi: 10.1016/j.metabol.2010.04.010. Epub 2010 Jun 26.

PMID:
20580039
2.

Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus.

Chang YH, Huang CN, Wu CY, Shiau MY.

Hum Immunol. 2005 Dec;66(12):1258-63. Epub 2006 Mar 13.

PMID:
16690414
4.

TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients.

Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, Chang YH.

Tissue Antigens. 2003 May;61(5):393-7.

PMID:
12753658
5.

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians.

Vozarova B, Fernández-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, Ricart W, Vendrell J, Richart C, Tataranni PA, Wolford JK.

Hum Genet. 2003 Apr;112(4):409-13. Epub 2003 Feb 14.

PMID:
12589429
6.

[Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].

Wei M, Lu YS, Li PP.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Apr;26(2):219-22. doi: 10.3760/cma.j.issn.1003-9406.2009.02.023. Chinese.

PMID:
19350521
7.

Association among interleukin-6 gene polymorphism, diabetes and periodontitis in a Chinese population.

Xiao LM, Yan YX, Xie CJ, Fan WH, Xuan DY, Wang CX, Chen L, Sun SY, Xie BY, Zhang JC.

Oral Dis. 2009 Nov;15(8):547-53. doi: 10.1111/j.1601-0825.2009.01584.x. Epub 2009 Jun 22.

PMID:
19549135
8.

Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.

Achyut BR, Srivastava A, Bhattacharya S, Mittal B.

Clin Chim Acta. 2007 Feb;377(1-2):163-9. Epub 2006 Oct 27.

PMID:
17069782
9.

Association of IL-4 receptor gene polymorphisms with high density lipoprotein cholesterol.

Chang YH, Huang CN, Shiau MY.

Cytokine. 2012 Aug;59(2):309-12. doi: 10.1016/j.cyto.2012.04.023. Epub 2012 May 24.

PMID:
22633285
10.

Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.

Drzewoski J, Sliwińska A, Przybyłowska K, Sliwiński T, Kasznicki J, Zurawska-Klis M, Kosmalski M, Majsterek I.

Kardiol Pol. 2008 Oct;66(10):1042-8; discussion 1049.

11.

Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.

Rigoli L, Raimondo G, Di Benedetto A, Romano G, Porcellini A, Campo S, Corica F, Riccardi G, Squadrito G, Cucinotta D.

Acta Diabetol. 1995 Dec;32(4):251-6.

PMID:
8750764
12.

Genetic polymorphisms in the transforming growth factor beta-induced gene associated with BMI.

Park KS, Shin HD, Park BL, Cheong HS, Choa YM, Lee HK, Lee JY, Lee JK, Kim HT, Han BG, Kim JW, Koh I, Kim YJ, Kimm K, Oh B.

Hum Mutat. 2005 Mar;25(3):322.

PMID:
15712349
13.

Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.

Mtiraoui N, Ezzidi I, Kacem M, Ben Hadj Mohamed M, Chaieb M, Haj Jilani AB, Mahjoub T, Almawi WY.

Diabetes Metab Res Rev. 2009 Jan;25(1):57-63. doi: 10.1002/dmrr.892.

PMID:
19031431
14.

The endothelial dysfunction in patients with type 2 diabetes mellitus is associated with IL-6 gene promoter polymorphism in Chinese population.

Zhang X, Ma L, Peng F, Wu Y, Chen Y, Yu L, Lei Z, Zhang C.

Endocrine. 2011 Aug;40(1):124-9. doi: 10.1007/s12020-011-9442-9. Epub 2011 Mar 18.

PMID:
21424184
15.
16.

Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.

Koh SJ, Jang Y, Hyun YJ, Park JY, Song YD, Shin KK, Chae JS, Kim BK, Ordovas JM, Lee JH.

Clin Endocrinol (Oxf). 2009 Feb;70(2):238-44. doi: 10.1111/j.1365-2265.2008.03315.x. Epub 2008 Jun 20.

PMID:
18573122
17.

Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.

Buraczynska M, Swatowski A, Buraczynska K, Dragan M, Ksiazek A.

Clin Sci (Lond). 2009 Jan;116(1):81-6. doi: 10.1042/CS20070411.

PMID:
18518860
18.

Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.

Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY.

Clin Endocrinol (Oxf). 2009 Mar;70(3):401-7. doi: 10.1111/j.1365-2265.2008.03337.x. Epub 2008 Jun 27.

PMID:
18616700
19.

Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.

Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF.

Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):38-41.

PMID:
17286233
20.

Supplemental Content

Support Center